Related Experiment Video
Updated: Apr 28, 2026
07:51
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
21.3K
Methylene blue unresponsive methemoglobinemia
Sibabratta Patnaik1, Manivachagan Muthappa Natarajan1, Ebor Jacob James1
1Department of Pediatrics, Pediatric Intensive Care Unit, Christian Medical College, Vellore, Tamil Nadu, India.
Summary
Severe toxic methemoglobinemia, a rare blood disorder, can be diagnosed using pulse-oximetry and blood gas analysis. This case highlights exchange transfusion as a successful treatment when methylene blue therapy fails.
Area of Science:
- Hematology
- Toxicology
Background:
- Acquired methemoglobinemia is an uncommon blood disorder.
- It is induced by exposure to oxidizing agents and drugs.
- Diagnosis can be challenging without a clear history of toxin ingestion.
Observation:
- Pulse-oximetry and blood gas analysis are crucial diagnostic tools.
- Prompt recognition is vital for emergency treatment.
- Methylene blue is the standard therapy.
Findings:
- This report details an unusual case of severe toxic methemoglobinemia.
- The condition was refractory to standard methylene blue treatment.
- Successful management was achieved with exchange transfusion.
Implications:
- Exchange transfusion is a viable alternative for severe methemoglobinemia unresponsive to methylene blue.
- This case expands treatment options for this rare blood disorder.
- Highlights the importance of considering alternative therapies in critical care settings.
Related Concept Videos
01:25Mechanism of Antibiotic Resistance in MRSA
215
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
215
01:23Hypoxia
2.4K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.4K
01:17Phase II Reactions: Methylation Reactions
912
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
912
01:25Clinical Significance of Antibiotic Resistance
90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90